SCYNEXIS INC (SCYX:NASDAQ)
$3.81 0.025 (0.6605%)
Analysed SCYNEXIS INC (SCYX:NASDAQ) News Sources
SCYNEXIS to Participate in Upcoming Investor Conferences
01-09-2026
yahoo.com
SCYNEXIS Announces Appointment of Sanjay Subramanian as Chief Financial Officer
10-09-2026
yahoo.com
SCYNEXIS Appoints Todd Minga, M.D., as Senior Vice President, Research & Development
15-09-2026
yahoo.com
SCYNEXIS Appoints Seasoned Industry Veteran Steven K. Burke, M.D., to its Board of Directors
22-09-2026
yahoo.com
SCYNEXIS Awarded BARDA Contract Providing Up to $214 Million in Non-Dilutive Funding for the Development of SCY-247
28-09-2026
yahoo.com
Scynexis Shares Rise 13.9% After BARDA Awards SCY-247 Development Contract
28-09-2026
advfn.com
Scynexis stock surges on $214M BARDA contract for SCY-247
28-09-2026
yahoo.com
SCYNEXIS Announces Phase 1 Study Results for SCY-770, a Novel, Highly Selective, Oral Direct AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
06-10-2026
yahoo.com
SCYNEXIS to Feature SCY-247 in a Pipeline Presentation at IDWeek
21-10-2026
yahoo.com
SCYNEXIS Completes Phase 1 Study of Intravenous SCY-247, a Novel, Triterpenoid Antifungal in Development for Treatment and Prevention of Invasive Fungal Diseases
22-10-2026
yahoo.com
What is the current price of SCYNEXIS INC (SCYX:NASDAQ)?
The current price of SCYNEXIS INC (SCYX:NASDAQ) is $3.81.
SCYNEXIS INC (SCYX:NASDAQ) absolute price change since previous trading day?
The absolute price change of SCYNEXIS INC (SCYX:NASDAQ) since the previous trading day is $0.025.
SCYNEXIS INC (SCYX:NASDAQ) percentage price change since previous trading day?
The percentage price change of SCYNEXIS INC (SCYX:NASDAQ) since the previous trading day is 0.6605%.
What is the most recent average sentiment score for SCYNEXIS INC (SCYX:NASDAQ)?
The most recent average sentiment score for SCYNEXIS INC (SCYX:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for SCYNEXIS INC (SCYX:NASDAQ)?
The most recent sentiment for SCYNEXIS INC (SCYX:NASDAQ) is .
SEC-8K** Filing Available For SCYNEXIS INC (SCYX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.